Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-06-27

Clinical Trial Update: Bupropion Treatment for Youth Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bupropion for youth smoking cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: University of Arizona | Conditions: Nicotine Dependence | Phase 3 | Status: COMPLETED